JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 49 filers reported holding JANUX THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,000 | +61.9% | 3,397 | +90.5% | 0.00% | – |
| Q2 2023 | $21,000 | +75.0% | 1,783 | +85.7% | 0.00% | – |
| Q1 2023 | $12,000 | -57.1% | 960 | -56.0% | 0.00% | – |
| Q4 2022 | $28,000 | +833.3% | 2,181 | +832.1% | 0.00% | – |
| Q3 2022 | $3,000 | +200.0% | 234 | +141.2% | 0.00% | – |
| Q2 2022 | $1,000 | -93.8% | 97 | -91.1% | 0.00% | – |
| Q1 2022 | $16,000 | -72.4% | 1,092 | -63.0% | 0.00% | – |
| Q4 2021 | $58,000 | -4.9% | 2,952 | +4.1% | 0.00% | – |
| Q3 2021 | $61,000 | +90.6% | 2,837 | +118.2% | 0.00% | – |
| Q2 2021 | $32,000 | – | 1,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $104,914,792 | 2.38% |
| EcoR1 Capital, LLC | 3,838,486 | $46,445,681 | 1.50% |
| Samsara BioCapital, LLC | 360,414 | $4,361,009 | 0.90% |
| BVF INC/IL | 1,585,677 | $19,186,692 | 0.70% |
| Orbimed Advisors | 2,836,386 | $34,320,271 | 0.67% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 900,000 | $10,890,000 | 0.02% |
| Woodline Partners LP | 137,300 | $1,661,330 | 0.02% |
| Vident Investment Advisory, LLC | 55,483 | $671,344 | 0.02% |
| JANUS HENDERSON GROUP PLC | 1,869,076 | $22,611,527 | 0.02% |
| FMR LLC | 10,281,288 | $124,403,584 | 0.01% |